FDA Inspection 1325188 — Tara Seery, MD

Tara Seery, MD — FEI 3044258030

The FDA completed an inspection of Tara Seery, MD on Jul 15, 2026 in El Segundo, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jul 15, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
El Segundo, CA (United States)

Additional Details

Sponsor-Investigator (S-I)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.